1978
DOI: 10.1002/ana.410040616
|View full text |Cite
|
Sign up to set email alerts
|

Carnitine deficiency: Acute postpartum crisis

Abstract: A 16-year-old girl, previously in good health, developed progressive generalized muscle weakness following her first parturition. The neck and proximal limb muscles were especially weak and painful. Carnitine (4-trimethylamino-3-hydroxybutyrate) was markedly decreased in muscle, plasma, and urine. Dietary carnitine supplementation, 2.0 gm daily, was followed by clinical improvement and decreased lipid droplets in muscle biopsy. Together with previously reported cases, 2 fatal, the patient's illness emphasizes … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
2
1

Year Published

1980
1980
2017
2017

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 49 publications
(14 citation statements)
references
References 18 publications
0
11
2
1
Order By: Relevance
“…Does lipid continue to accumulate in the muscles with an inverse ratio to carnitine concentrations, or is there a threshold value below which lipid-storage occurs? As illustrated in figure 4 the levels of muscle free-carnitine detected in haemodialysis patients fall within an intermediate range between those observed in carnitine deficiency myopathies (2.06 ±0.54 pmol/g NCP) [16][17][18][19][20][21][22][23] and those of our con- trols. Thus we suggest that a free-carnitine threshold value for lipid storage does exist and may correspond to the mean value observed in carnitine deficiency myopathies.…”
Section: J-----------------------------------------------------------mentioning
confidence: 75%
“…Does lipid continue to accumulate in the muscles with an inverse ratio to carnitine concentrations, or is there a threshold value below which lipid-storage occurs? As illustrated in figure 4 the levels of muscle free-carnitine detected in haemodialysis patients fall within an intermediate range between those observed in carnitine deficiency myopathies (2.06 ±0.54 pmol/g NCP) [16][17][18][19][20][21][22][23] and those of our con- trols. Thus we suggest that a free-carnitine threshold value for lipid storage does exist and may correspond to the mean value observed in carnitine deficiency myopathies.…”
Section: J-----------------------------------------------------------mentioning
confidence: 75%
“…62 Plasma carnitine levels normally fall during pregnancy. 4 A deficiency of carnitine can cause a progressive myopathy associated with elevated serum CK levels and biopsy evidence of a necrotizing myopathy with abundant lipid storage droplets in muscle fibers. Women with carnitine-deficiency myopathy can deteriorate in the months postpartum; a 19-year-old woman with carnitine deficiency died within a year of delivery; another woman died within 2 years after delivery.…”
Section: Inherited Disorders Of Nerve and Muscle Complicating Pregnancymentioning
confidence: 99%
“…15,31 In other reports, weakness associated with carnitine deficiency is first evident in the postpartum months; two women were treated with supplemental carnitine, and one improved. 4,65 Cytochrome oxidase deficiency mitochondrial myopathy can lead to increased pain, fatigue, and reduced maternal mobility necessitating delivery by caesarian section. 117 However, Blake and Shaw advocated trying to avoid the rigors of caesarian section.…”
Section: Inherited Disorders Of Nerve and Muscle Complicating Pregnancymentioning
confidence: 99%
“…The patient after carnitine supplementation did not regain full functionality but neither did she become any worse. Three more case reports by Boudin et al [17], and Cornelio et al [18] and Angelini et al [16] reported necrotising myopathies during pregnancy and post-partum. In the first two cases by Boudin and Cornelio, no therapy was effective and death ensued within 1 and 2 years, respectively.…”
mentioning
confidence: 95%
“…There is increasing evidence that these antibodies activate interferon-alpha (IFNalpha) in plasmatocytic dendritic cells that could be very important in facilitating immune-mediated processes that induce myopathy [7,13,14]. The main treatment for necrotising immune-mediated myopathies has so far been methylprednisolone with good results, discontinuation of the statin use where applicable [1,3,6] and carnitine supplementation, where there was deficiency [15][16][17][18].…”
mentioning
confidence: 99%